3/28
08:20 am
iccm
IceCure Medical Ltd (NASDAQ: ICCM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $2.50 price target on the stock.
Low
Report
IceCure Medical Ltd (NASDAQ: ICCM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $2.50 price target on the stock.
3/27
08:59 am
iccm
IceCure Medical Reports 2024 Financial Results: 42% Growth in ProSense® Cryoablation Sales in North America [Yahoo! Finance]
Medium
Report
IceCure Medical Reports 2024 Financial Results: 42% Growth in ProSense® Cryoablation Sales in North America [Yahoo! Finance]
3/27
08:30 am
iccm
IceCure Medical Reports 2024 Financial Results: 42% Growth in ProSense® Cryoablation Sales in North America
Medium
Report
IceCure Medical Reports 2024 Financial Results: 42% Growth in ProSense® Cryoablation Sales in North America
3/24
09:00 am
iccm
IceCure's ICESECRET Kidney Cancer Cryoablation Study Interim Results Presented at European Association of Urology Conference in Spain: 88.7% Recurrence-Free Rate [Yahoo! Finance]
Low
Report
IceCure's ICESECRET Kidney Cancer Cryoablation Study Interim Results Presented at European Association of Urology Conference in Spain: 88.7% Recurrence-Free Rate [Yahoo! Finance]
3/24
08:30 am
iccm
IceCure's ICESECRET Kidney Cancer Cryoablation Study Interim Results Presented at European Association of Urology Conference in Spain: 88.7% Recurrence-Free Rate
Low
Report
IceCure's ICESECRET Kidney Cancer Cryoablation Study Interim Results Presented at European Association of Urology Conference in Spain: 88.7% Recurrence-Free Rate
3/21
09:30 am
iccm
IceCure Medical to Report 2024 Full Year Financial & Operational Results on March 27, 2025 [Yahoo! Finance]
Low
Report
IceCure Medical to Report 2024 Full Year Financial & Operational Results on March 27, 2025 [Yahoo! Finance]
3/21
08:30 am
iccm
IceCure Medical to Report 2024 Full Year Financial & Operational Results on March 27, 2025
Low
Report
IceCure Medical to Report 2024 Full Year Financial & Operational Results on March 27, 2025
3/20
08:30 am
iccm
IceCure Reports Updated Timeline and Progress with FDA Regarding Marketing Authorization for ProSense® Cryoablation in Early-Stage Breast Cancer
High
Report
IceCure Reports Updated Timeline and Progress with FDA Regarding Marketing Authorization for ProSense® Cryoablation in Early-Stage Breast Cancer
3/18
08:30 am
iccm
IceCure's ProSense® Cryoablation Featured in Six Studies Presented at St. Gallen International Breast Cancer Conference
Medium
Report
IceCure's ProSense® Cryoablation Featured in Six Studies Presented at St. Gallen International Breast Cancer Conference
3/17
08:47 am
iccm
IceCure Receives Notice of Allowance in China for Novel Cryogenic Pump for Next-Generation Cryoablation Technology [Yahoo! Finance]
Low
Report
IceCure Receives Notice of Allowance in China for Novel Cryogenic Pump for Next-Generation Cryoablation Technology [Yahoo! Finance]
3/17
08:30 am
iccm
IceCure Receives Notice of Allowance in China for Novel Cryogenic Pump for Next-Generation Cryoablation Technology
Low
Report
IceCure Receives Notice of Allowance in China for Novel Cryogenic Pump for Next-Generation Cryoablation Technology
3/10
09:04 am
iccm
Breast Cancer Patients who Underwent IceCure's ProSense® Cryoablation in Japan Reported Significantly Higher Satisfaction than Patients who Underwent Standard of Care Surgery [Yahoo! Finance]
Medium
Report
Breast Cancer Patients who Underwent IceCure's ProSense® Cryoablation in Japan Reported Significantly Higher Satisfaction than Patients who Underwent Standard of Care Surgery [Yahoo! Finance]
3/10
08:30 am
iccm
Breast Cancer Patients who Underwent IceCure's ProSense® Cryoablation in Japan Reported Significantly Higher Satisfaction than Patients who Underwent Standard of Care Surgery
Medium
Report
Breast Cancer Patients who Underwent IceCure's ProSense® Cryoablation in Japan Reported Significantly Higher Satisfaction than Patients who Underwent Standard of Care Surgery
2/24
09:07 am
iccm
IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense™ Cryoablation System in Israel [Yahoo! Finance]
Medium
Report
IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense™ Cryoablation System in Israel [Yahoo! Finance]
2/24
08:30 am
iccm
IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense™ Cryoablation System in Israel
Medium
Report
IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense™ Cryoablation System in Israel
2/4
08:30 am
iccm
IceCure's ProSense® in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates FDA's Market Authorization Decision
Low
Report
IceCure's ProSense® in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates FDA's Market Authorization Decision
1/27
08:30 am
iccm
IceCure Files for Regulatory Approval of ProSense® Cryoablation System in China
Low
Report
IceCure Files for Regulatory Approval of ProSense® Cryoablation System in China
1/13
07:00 am
iccm
IceCure Medical CEO Issues Letter to Shareholders & Reports Increase of 42% in ProSense® Sales for 2024 in North America
High
Report
IceCure Medical CEO Issues Letter to Shareholders & Reports Increase of 42% in ProSense® Sales for 2024 in North America
1/6
09:09 am
iccm
IceCure Medical Regains Full Nasdaq Compliance with Nasdaq Minimum Closing Bid Price Rule [Yahoo! Finance]
Medium
Report
IceCure Medical Regains Full Nasdaq Compliance with Nasdaq Minimum Closing Bid Price Rule [Yahoo! Finance]
1/6
08:47 am
iccm
IceCure Medical regains compliance with Nasdaq [Seeking Alpha]
Medium
Report
IceCure Medical regains compliance with Nasdaq [Seeking Alpha]
1/6
08:30 am
iccm
IceCure Medical Regains Full Nasdaq Compliance with Nasdaq Minimum Closing Bid Price Rule
Medium
Report
IceCure Medical Regains Full Nasdaq Compliance with Nasdaq Minimum Closing Bid Price Rule
1/3
08:30 am
iccm
European Patent Office Issues Intention to Grant Notice to IceCure for its Next-Generation Cryoablation Technology
Low
Report
European Patent Office Issues Intention to Grant Notice to IceCure for its Next-Generation Cryoablation Technology